Race Oncology Raises AU$1 Million in Strategic Placement
MT Newswires Live
Jun 04
Race Oncology (ASX:RAC) secured around AU$1 million via a targeted private placement with a specialist healthcare-focused institutional investor, issuing 526,315 fully paid ordinary shares at AU$1.90 each, representing a 23% discount to its recent average market price, according to a Thursday filing with the Australian bourse.
The company has raised a total of AU$31.2 million, including this placement and recent funds from piggyback and bonus option offers, to support the clinical development of RC220 and general working capital requirements, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.